Macrogenics (MGNX) EBIT Growth (1y) (2013 - 2026)
Macrogenics (MGNX) EBIT Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 21.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.55% |
| Dec 31, 2025 | 77.11% |
| Sep 30, 2025 | -65.61% |
| Jun 30, 2025 | 36.82% |
| Mar 31, 2025 | 20.70% |
| Dec 31, 2024 | -7.06% |
| Sep 30, 2024 | 252.64% |
| Jun 30, 2024 | -29.40% |
| Mar 31, 2024 | -39.88% |
| Dec 31, 2023 | -511.87% |
| Sep 30, 2023 | -42.26% |
| Jun 30, 2023 | -7.54% |
| Mar 31, 2023 | 42.34% |
| Dec 31, 2022 | 120.58% |
| Sep 30, 2022 | 52.90% |
| Jun 30, 2022 | -3.80% |
| Mar 31, 2022 | -29.92% |
| Dec 31, 2021 | -2,583.69% |
| Sep 30, 2021 | -46.64% |
| Jun 30, 2021 | 14.86% |